TrialClinical cancer research : an official journal of the American Association for Cancer Research2015

The high-dose aldesleukin "select" trial: a trial to prospectively validate predictive models of response to treatment in patients with metastatic renal cell carcinoma.

David F McDermott et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.